key: cord-0763920-gvr9w3qh
authors: Zeegen, Erik N.; Yates, Adolph J.; Jevsevar, David S.
title: After the COVID-19 pandemic: returning to normalcy or returning to a new normal?
date: 2020-04-22
journal: J Arthroplasty
DOI: 10.1016/j.arth.2020.04.040
sha: 19bedd74d6cd6d6681a500e7a6767c61eeae06ca
doc_id: 763920
cord_uid: gvr9w3qh

Abstract The novel coronavirus, SARS-CoV-2, pandemic has delivered a profound and negative impact on the United States. The suspension of elective surgeries including arthroplasty will have a lasting effect on all stakeholders including patients, physicians, and healthcare organizations within the US healthcare system. Resumption of elective hip and knee arthroplasty will need to be carefully focused. The purpose of this work is to address potential strategies, concerns, and regulatory barriers in restarting elective hip and knee arthroplasty in the US.

A novel coronavirus, now called severe acute respiratory coronavirus 2 (SARS-Cov-2), 9 began in Wuhan, Hubei province, China and is now a public health emergency of international 10 concern. 1,2 In the United States, the COVID-19 pandemic has led to widespread social 11 distancing, shelter-in-place, and workplace closures. Because of concerns for healthcare 12 resources in initial US pandemic modeling and the experience within New York City and 13 surrounding areas, the US Surgeon General and the Centers for Medicare and Medicaid Services 14 issued guidance to stop performing elective surgeries in the United States. [3] [4] [5] This 15 recommendation was based on concerns for the quantity of personal protective equipment 16 (PPE) present within the United States. A recent report regarding the COVID-19 pandemic from 17 the U.S. Department of Health and Human services showed that hospitals are experiencing 18 increasing costs and decreasing revenues which threaten their financial viability. Hospitals have 19

reported that ceasing elective procedures and other services has decreased revenues while 20 their costs have increased as they prepare for a potential surge of patients. Many hospitals 21 reported that their cash reserves are quickly depleting, which could disrupt ongoing hospital 22 operations 6 . As predictive models of the impact of COVID-19 on the United States continue to 23 be refined with more data, the delivery of healthcare services outside of COVID-19 must be 24 addressed. 25

One of the more commonly-cited COVID-19 projection models is produced by the 26 Institute for Health Metrics and Evaluation at the University of Washington. Their current 27 projections show that April 11, 2020 will be the day with maximum resource utilization (ICU 28 beds, ventilators) within the US. This model assumes that social distancing will be in place until 29 the death rate from COVID-19 falls below 0.3/million people, or likely through the end of May. 30 It also forecasted zero deaths in July and August from The 2020 COVID-19 pandemic has drastically negatively affected the US economy. While 40 the traditional definition of a recession necessitates two quarters of economic downturn, many 41 have already referred to the US as in a recession. 8 A systematic review showed that economic 42 downturn generally decreases the volume of most elective surgical procedures, although a few 43 procedures increased in volume. 9 One study reported that the rate of cancellations of total 44 joint arthroplasties was increased during the last economic recession, and appeared to be 45 related to unemployment and consumer confidence. 10 Conversely, another study using the US 46

Nationwide Inpatient Sample showed that the 2007 economic recession did not substantially 47 influence growth trends in total hip and total knee arthroplasty. Importantly, the acute 48 economic downturn could result in the loss of employer-provided healthcare insurance for 12 49 to 35 million people, with an increase of 11 to 13 million people enrolled in Medicaid, and the 50 number of uninsured could increase to 40 million with bigger impacts in Medicaid non-expansion states. 11 The economic downturn and associated volatility have the potential to 52 meaningfully impact the volume of elective total joint arthroplasty procedures. 53 As the medical system looks ahead to resume elective arthroplasty cases, there are 54 certain financial issues to be considered. As with the so-called practice of "cherry-picking" and 55 "lemon-dropping" of patients based on the case complexity and resource requirements, an 56 analogous scenario exists with the payor mix. By the time elective surgeries are resumed, the 57 medical system will be under considerable financial strain due to a several month hiatus of 58 incoming revenue. As such, there will be enormous pressure to quickly ramp up surgical volume 59 to meet both the financial needs of the institution as well as the medical needs of the large 60 cohort of patients whose surgical procedures were put on hold because of the COVID-19 61 pandemic. There could very well be a tendency to prioritize patients with straightforward cases 62 who have minimal comorbidities and insurance plans with favorable reimbursement fees. 63

Previous studies have demonstrated that patients with increased medical comorbidities can 64 increase the risk of postoperative complications which can lead to increased costs to the 65 medical system 12-17 . It has also been shown that economically disadvantaged patients have 66 lower function and quality of life before and after total joint arthroplasty 18,19 and experience 67 higher risk for certain complications and use more resources after primary total joint 68 arthroplasty when compared with non-economically disadvantaged patients 20 . With this in 69 mind, there is potential for a widening disparity of care for those who are most vulnerable and 70 for the underserved to become even less served. 21,22 It remains to be seen how the systems will 71 address these potential disparities while striving for economic stability.

The resurgence of elective surgeries will likely require abundant administrative 73 resources. In order to meet these demands, optimizing hospital and practice administrative 74 resources for scheduling surgeries, obtaining pre-authorization (when necessary), and 75 coordinating preoperative medical clearances will be critical to avoid an overwhelming 76 situation. Moreover, insurance companies will need to be ready on their end to process the 77 large number of pre-authorization requests. It is unclear whether the healthcare administrative 78 and payer infrastructure will be able to withstand the potential vast increase in surgeries in the 79 post-COVID period. 80

For academic programs during this time period, financial regrowth and optimizing 81 efficiency may be at odds with resident and fellow education. Previous reports have 82 demonstrated longer operative times, greater healthcare resource utilization, longer hospital 83 stays, and higher costs at teaching hospitals 23-25 . Balancing the need for efficiency and cost 84 mindfulness with the need to educate residents and fellows in the operating room may be 85 challenging. One solution to this may be to utilize midlevel staff (i.e. physician assistants and 86 nurse practioners) to help with the increased caseload and overall throughput in the hospital, 87 and thereby facilitate attending surgeons' ability to continue with resident and fellow 88 education. Also, to address the backlog of postponed surgeries and remain efficient, hospital 89 systems may need to utilize multiple "flip rooms" rooms with extended hours into the evening 90 and weekends. Initially this may result in an increased overhead as there will a time-lag 91 between the start of elective surgery recommencing and receipt of payments. But over time, 92 the revenue stream will be revived, and hopefully economic equilibrium will be achieved. 93 known positive or suspected COVID-19 patients is still under discussion. At the time of this 96 writing, the only tests available for detecting the virus are nasopharyngeal swab or 97 bronchoalveolar lavage PCR rapid testing for the SARS-CoV-2 genetic material. Some 98 institutions with capacity for testing have implemented preoperative testing for all 99 preoperative patients. For non-emergent, urgent elective cases, a COVID-19 test is obtained 48 100 hours prior to the scheduled procedure. If test is negative, then surgery may proceed as 101 scheduled with patient and surgeon understanding that the true false negative rate for testing 102 in asymptomatic patients is unknown. However, if the test is positive and the procedure can be 103 delayed, the surgery is rescheduled for a later date. 104

Antibody testing may be another means to assess patients' COVID-19 status. There is 105 still only preliminary data regarding the antibody response that occurs after exposure to the 106 novel Coronavirus. In a recent study out of China, the median duration of IgM and IgA antibody 107 detection were 5 days, while IgG was detected 14 days after symptom onset 26 . It remains 108 unknown for how long the IgG antibody response will persist, and whether it will confer long 109 term immunity. Nonetheless, serologic testing for antibodies to the SARS-COV-2 virus is under 110 development for clinical use. On April 1, 2020, the Food and Drug Administration approved the 111 first commercial serologic test in the U.S. It is anticipated that there will be several commercial 112 tests available in the near future. Antibody testing would provide a clearer understanding of 113 the prevalence and fatality rate of the disease, since it could identify patients who had the virus 114 even if they had mild or no symptoms. The widespread utilization of antibody testing may also 115 have a large impact on the clinical care pathways for arthroplasty patients as it may have implications for an enhanced ability to segregate patients into known immune and non-immune 117 categories (if the case for long-term immunity can be proven with IgG antibody detection). This 118 may facilitate the establishment of separate COVID-19 and non-COVID-19 zones within a 119 hospital or perhaps even the designation of dedicated COVID-19 and non-COVID-19 hospitals. 120

This also raises the question of how to maintain underutilized staff within the hospital 121 during the ongoing pandemic surge and keep them healthy and prepared to resume elective 122 surgical procedures once the temporary restriction is lifted. There have been some reports of 123 health systems cutting the salaries of underutilized medical staff or even furloughing them 124 during this crisis. 27 Other health systems have proposed re-purposing staff to help with the 125 overwhelming number of COVID-19 patients that are engulfing much of the financial and 126 manpower resources within the hospital systems. . With the passage of the recent Coronavirus 127

Aid, Relief, and Economic Security Act ("CARES Act"), $100 billion has been made available to 128 "eligible health care providers" for health care-related expenses or lost revenues attributable to 129 the COVID-19 pandemic. This influx of emergency financial assistance may help offset lost 130 revenue during the pandemic and permit the preservation of a healthy workforce which would 131 be well-prepared for redeployment. 132

Another issue which will likely require significant attention is how to decide which 133 patients should receive priority for proceeding with surgery once elective surgeries are 134 reinstated. It is likely that elective procedures will slowly be reinstated in a staged fashion over 135 a period of weeks to months once the surge has passed. Since SARS-CoV-2 is a newly identified 136 pathogen, there is no pre-existing immunity to it in the human community, and there is no 137 definitive cure to treat the disease. This is problematic for all patients. However, the elderly, those with underlying chronic conditions, and those with weakened immune systems are 139 particularly vulnerable. From the early experience with COVID-19 in China, it was reported in a 140 recent JAMA article that those aged 70 to 79 years had an 8.0% case fatality rate (CFR), and in 141 those aged 80 years and older the CFR was 14.8%. The CFR was notably elevated among those 142 with preexisting comorbid conditions-10.5% for cardiovascular disease, 7.3% for diabetes, 143 6.3% for chronic respiratory disease, 6.0% for hypertension, and 5.6% for cancer 28 Because of this and the overall significantly higher mortality rate, the authors hypothesized that 155 surgery may accelerate and exacerbate disease progression of COVID-19 30 . As such, it may be 156 reasonable to initially restrict elective arthroplasty surgery to those patients without significant 157 medical comorbidities during the early stages of resuming elective procedures when there will 158 still be some degree of COVID-19 patients present in the hospital. This could minimize the risk 159 of postoperative patients developing severe disease should they be exposed and infected with 160 the Coronavirus. Analysis of US Medicare data reveals substantial regional variation in patients 161 at the highest risk, and rates of arthroplasty resumption may concomitantly differ. 31 As the 162 census of COVID-19 patients begins to diminish, it may then be safe to re-introduce patients 163 with more concerning comorbid diseases into the hospital setting to undergo elective surgical 164 procedures in parallel pathways of care. 165

One of the considerations moving forward is to further increase the volume of 166 outpatient arthroplasties in a non-hospital setting. This approach is attractive because an 167 ambulatory surgery center located remote from a hospital might be better able to isolate and Regardless of the location of the procedure, it is likely that there will be increased 184 demands placed on surgeons to handle the large volume of procedures that will need to be 185 performed over the course of the next several months. Questions will arise as to how we as 186 surgeons will meet this demand and maintain quality care and safety for our patients, as well as in a day along with the case order is also important. A recent study demonstrated that surgical 202 case order is an independent risk factor for adverse events in arthroplasty procedures, with 203 procedures performed later in the day having a higher risk for arthroplasty specific adverse 204 events (but not for systematic adverse events). Significantly increased operative time, higher 205 cost, and longer length of stay were noted for fourth or later arthroplasty cases (p<0.01) 56 . 206 Taking this all into consideration will be critical to developing a safe and efficient 207 strategy for moving forward once elective surgeries are reinstated. Fatigue risk mitigation and 208 enhanced safety strategies have been outlined by Janofer et al. Key components include 209 comprehensive preoperative planning, promoting fatigue awareness, and taking intra-operative 210 "microbreaks" 53 . Some of the key applications of these strategies include establishment of 211 clear operative team roles, responsibilities and assigned tasks in a preoperative team brief, 212 reduction of need for extra intraoperative decisions, optimization of surgeon sleep, nutrition, 213 and hydration to maximize surgeon endurance, and establishment of a detailed backup 214 contingency plan 53 . Preoperative safety checklists are another procedural safeguard to help 215 ensure patient safety. It has been shown in multiple studies that performance of a preoperative 216 safety checklist reduces wrong site surgery, improves timely administration of prophylactic 217 antibiotics, and decreases postoperative complications and mortality 57,58 . 218 How to optimally balance the needs for processing a large surgical volume with patient 219 and staff safety will likely be varied and institutionally dependent. However, there have been 220 several reports in the literature outlining integral strategies to successfully yield high operative 221 efficiency and productivity. A paper by Attarian et al. reported improved OR efficiency and 222 productivity via improved communication, elimination of silo mentalities, enhanced team work, 223 and high-efficiency OR teams adapting parallel processing 59 . Implementation of these types of 224 strategies, particularly enhanced communication with anesthesia, OR staff, and central 225 processing for short turnover times will be crucial for high efficiency and productivity. One of 226 the more profound tenets identified in this paper for the success of the program was "sincere 227 gratitude to the team players every day" 59 This has occurred in part already on April 8, 2020, with the ABOS announcing changes to the 251 case collection period. 62 They had already allowed for time away limits to be averaged over 252 time.

They have yet to change the dates for written and oral boards in July of this year; given 253 the disruption, postponing both by 4 to 8 weeks would probably be welcomed by applicants. 254

Finally, failure on the written boards is usually accompanied by notification that the applicant is 255 unable to self-describe as "board eligible" until passing; again, given the disruption, relaxing 256 that rule to allow for one failed exam before receiving that status could be understood to be a 257 one-time exception. 258

All normal time-lines should be negotiable. A collective action by fellowships to allow for 259 an extra month before new fellows start would allow the programs to keep their current 260 fellows an extra month if outside practices and hospitals do not have the reserves to hire at this 261 time. The funding for graduate medical education could be revised for one year to allow for 262 current Chief residents to stay as instructors with a salary increase for one or two months 263 awaiting to start fellowship. In both cases, the more site-specific efficiencies would be 264 maintained and the pandemic curve allowed to reach its nadir before multiple young physicians 265 move from one medical center to another throughout the country. 266

There has already been noteworthy short-term regulatory relief from the Centers for 267 when with residents could be relaxed such that the key or critical presence component has 269 been physically met for routine cases without having to document an available second surgeon. 270

The Center for Medicare and Medicaid Innovation had proposed a three-year extension of the 271 Comprehensive Care for Joint Replacement (CJR) alternative payment plan/bundle with new 272 rules; the current CJR has been extended to March 31,2021; in addition, caps on expenditures 273 were placed 30 days before and during the declared national emergency, and the Extreme and 274

Uncontrollable Circumstances policy applied to CJR, MIPS, and ACO's. 65,66 COVID-19 is a new 275 disease affecting the population broadly with yet to be defined long term consequence for 276 those who become ill, especially those of Medicare eligible age. The risk adjustments for CJR, 277

Value Based Purchasing, the Readmission Reduction Program, and the hospital and surgeon 278 specific cost measures are now hampered. The disease and its aftermath could arguably 279 warrant a new hierarchical condition category (HCC) to be considered in federal performance 280 measure risk models. Knowing its full impact may take time and clearly is going to be regionally 281 disparate; temporarily lifting those measures and their financial impacts could avoid undue 282 burdens on the hospitals of the regions hardest hit. 283

Clinical features of patients infected with 2019 novel 284 coronavirus in Wuhan

US Department of Health and Human Services

Surgeon general urges providers to consider stopping all elective surgeries -291 hospitals push back

AAOS Guidelines for Elective Surgery During the COVID-19

Hospital Experiences Responding to the COVID-19 Pandemic: Results of a 297 National Pulse Survey

Influenza pandemics of the 20th century

Recession Model at 100% Confirms Downturn Is 302

Recession Model at 100% Confirms Downturn Is Already 303 Here

The effect of economic downturn on the 305 volume of surgical procedures: A systematic review

The economic recession 307 and its effect on utilization of elective total joint arthroplasty

COVID-19 Impact on Medicaid, Marketplace, and the Uninsured, by 310 State

Bundled Payments: Our Experience at an Academic Medical Center

Higher Modified Charlson Index Scores 316

Are Associated With Increased Incidence of Complications, Transfusion Events, and 317 Length of Stay Following Revision Hip Arthroplasty

Hospital, Patient, and 320 Clinical Factors Influence 30-and 90-Day Readmission After Primary Total Hip 321 Arthroplasty

Patient Factors and Cost Associated 323 with 90-Day Readmission Following Total Hip Arthroplasty

Preoperative Patient Profile in Total Hip

Knee Arthroplasty: Predictive of Increased Medicare Payments in a Bundled Payment 327 Model

Granular Analysis of Outcomes in the Economically Disadvantaged Patient. The Journal 330 of Arthroplasty

The Effect of Payer Type on 332 Clinical Outcomes in Total Knee Arthroplasty

Impact of Payer Type on Resource Utilization, Outcomes and Access 334 to Care in Total Hip Arthroplasty

Medicaid payer status is associated with in-336 hospital morbidity and resource utilization following primary total joint arthroplasty

Using quantile regression to 339 examine health care expenditures during the Great Recession

The great recession and racial and ethnic disparities in health 342 services use

Is Orthopedic 344 Department Teaching Status Associated With Adverse Outcomes Of Primary Total Hip 345 Arthroplasty?

The cost of teaching total knee arthroplasty 347 surgery to orthopaedic surgery residents

A Comparison of the Results of Total Hip and Knee Arthroplasty 349 Performed on a Teaching Service or a Private Practice Service. The Journal of Bone & 350 Joint Surgery

Profiling Early Humoral Response to Diagnose Novel 352 Coronavirus Disease (COVID-19)

During a Pandemic, an Unanticipated Problem: Out-354 of-Work Health Workers

Characteristics of and Important Lessons From the Coronavirus 356 Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From 357 the Chinese Center for Disease Control and Prevention

Prevalence of comorbidities in the novel Wuhan 359 coronavirus (COVID-19) infection: a systematic review and meta-analysis

Clinical characteristics and outcomes of patients undergoing 362 surgeries during the incubation period of COVID-19 infection

Medicare Data Reveal Wide 365

Variety Across Regions Of COVID-19 Fatality Risk | Health

Outpatient Surgery as a Means of Cost 368 Reduction in Total Hip Arthroplasty: A Case-Control Study

Rapid 371 rehabilitation and recovery with minimally invasive total hip arthroplasty

Outpatient 374 Total Knee Arthroplasty With a Minimally Invasive Technique

Perioperative Solutions for Rapid Recovery Joint Arthroplasty: 379 Get Ahead and Stay Ahead

Rapid Recovery 381 Protocols for Primary Total Hip Arthroplasty Can Safely Reduce Length of Stay Without 382 Increasing Readmissions

Arthroplasty Has Minimal Short-Term Complications With the Use of Institutional 388 Protocols

An Evaluation of the 390 Safety and Effectiveness of Total Hip Arthroplasty as an Outpatient Procedure: A 391 Matched-Cohort Analysis

Rapid 393 Discharge in Total Hip Arthroplasty: Utility of the Outpatient Arthroplasty Risk 394

Assessment Tool in Predicting Same-Day and Next-Day Discharge

Inpatient Versus Outpatient Hip 397 and Knee Arthroplasty: Which Has Higher Patient Satisfaction?

Outpatient Joint Arthroplasty: A Systematic Review

Arthroplasty Be Performed Safely as an Outpatient in the Medicare Population? The 404

Is Outpatient 406 Total Hip Arthroplasty Safe?

Outpatient Joint Arthroplasty Patients With Medical Risk Stratification: the

Arthroplasty Risk Assessment Score

Complications Following Outpatient Total Joint 412 Arthroplasty: An Analysis of a National Database

Outpatient Joint Arthroplasty: A Systematic Review

Is Outpatient Arthroplasty Safe? A Systematic 417 Review

Knee Society, and American 420 Academy of Orthopaedic Surgeons Position Statement on Outpatient Joint 421 Replacement

An analysis of 30-day mortality after weekend versus 423 weekday elective joint arthroplasty in England and Wales: a cohort study using the 424 National Joint Registry Dataset

The Physical Workload of 426 Surgeons

Addressing Surgeon Fatigue: Current Understanding 428 and Strategies for Mitigation

Analysis of errors reported by 430 surgeons at three teaching hospitals

Surgeon 432 Fatigue

Impact of surgical case order on peri-434 operative outcomes for total joint arthroplasty

Effectiveness of Surgical Safety 437 Checklists in Improving Patient Safety

Systematic review and meta-analysis of the effect of 439 the World Health Organization surgical safety checklist on postoperative complications

Developing a High-efficiency Operating 442 Room for Total Joint Arthroplasty in an Academic Setting

Published 2020. 447 Accessed. 448 61. Notification of Enforcement Discretion for Telehealth Remote Communications During 449 the COVID-19 Nationwide Public Health Emergency. US Department of Health and 450 Human Services

Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the 457 COVID-19 Public Health Emergency. US Department of Health and Human Services

Medicare Program; Advancing Care Coordination Through Episode Payment Models 466 (EPMs)

Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for 468 Joint 469 Replacement Model; Delay of Effective Date. US Department of Health and Human Services

American Association 473 of Medical Colleges